My bookmarksSign up free

Commission Implementing Regulation (EU) 2022/1646 Article 3

Commission Implementing Regulation (EU) 2022/1646 Article 3

General provisions

Article 3

Member States shall ensure that the part of the MANCP concerning the performance of official controls on the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof in live animals and products of animal origin contains the following: (a) a ‘national risk-based control plan for production in the Member States’, as set out in Article 4; (b) a ‘national randomised surveillance plan for production in the Member States’ as set out in Article 5; (c) a ‘national risk-based control plan for third-country imports’ as set out in Article 6.

Read the full instrument → · Read this in context: CHAPTER II — SPECIFIC ADDITIONAL CONTENT OF THE MANCP →

Other provisions in CHAPTER II — SPECIFIC ADDITIONAL CONTENT OF THE MANCP

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 3 of Commission Implementing Regulation (EU) 2022/1646 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next